Michael Meyer

Michael Meyer serves as the Chief Technology Officer, where he plays a pivotal role in managing technical and clinical group collaborations and providing final technical arbitration at VisionGate. He brings a wealth of expertise in artificial intelligence, particularly in its application to medical diagnostics. Prior to his current role, Meyer was a research scientist at TriPath Imaging, Inc., leading the development of algorithms aimed at detecting cervical neoplasms and their precursors in Pap smear slides. Before his tenure at TriPath Imaging, Inc., he worked at IBM in Rochester, MN. His current work includes significant contributions to the development of the LuCED test, a groundbreaking early lung cancer detection test based on the Cell-CT platform.